We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Stocks rise but pound slumps on sub-par UK data

Wed, 23rd Aug 2023 12:10

(Alliance News) - Stocks in Europe were on the up heading into Wednesday afternoon, with equity markets in a confident mood on the eve of the Jackson Hole central banking event, shaking off tepid economic data which hurt the pound and euro.

Utility stocks were among the best performers in London's blue-chip FTSE 100 index, after a bullish note from Royal Bank of Canada on UK regulated utilities. National Grid and SSE added 2.4% and 2.2%, among the best large-cap performers.

It is a big day on the New York corporate calendar, meanwhile, with eagerly-awaited second-quarter results from Nvidia expected after the closing bell there. The chipmaker has been at the heart of an artificial intelligence boom, and its market value has soared above the USD1 trillion mark this year.

The FTSE 100 index climbed 50.00 points, 0.7%, at 7,320.76. The FTSE 250 added 148.46 points, 0.8%, at 18,172.72, and the AIM All-Share rose 2.08 points, 0.3%, at 734.26.

The Cboe UK 100 was up 0.7% at 729.69, the Cboe UK 250 was up 0.7% at 15,929.52, and the Cboe Small Companies rose 0.1% at 13,400.16.

In European equities on Wednesday, both the CAC 40 in Paris and the DAX in Frankfurt were up 0.4%.

Sterling was quoted at USD1.2632 early Wednesday afternoon, down markedly from USD1.2734 at the London equities close on Tuesday. The euro traded at USD1.0810, down from USD1.0851. Against the yen, the dollar was quoted at JPY145.50, down versus JPY145.79.

The pound hit a three-week low, while the single currency traded at its lowest level in two months.

"Poor European flash [purchasing managers' index readings] pushed on open door, giving the market a new reason to do what it was doing and that buying the dollar," Bannockburn Global Forex analyst Marc Chandler commented.

"The euro has approached important support around USD1.08 and sterling is approaching the lower end of its two-cent trading range (USD1.26-USD1.28)."

The UK private sector fell back into contraction in August, survey results suggested, amid a renewed deterioration in the services sector.

The S&P Global/CIPS flash UK composite purchasing managers' index fell to a 31-month low of 47.9 points in August from 50.8 in July.

Coming in below the 50-point no-change mark, it shows the UK private sector has fallen into contraction. Market expectations had been for a reading of 50.3, according to FXStreet-cited consensus.

After a string of readings showing growth, the flash services PMI fell to a seven-month low of 48.7 points in August from 51.5 in July and compared to expectations of 50.8. Manufacturing also deteriorated at a faster pace than expected, with the PMI falling to 42.5 from 45.3. It was a 39-month low and below market expectations of 45.0.

The downturn in the eurozone's private sector deepened, meanwhile. The Hamburg Commercial Bank flash composite PMI fell to a 33-month low of 47.0 points in August. The final reading for July was 48.6.

Ebury analyst Matthew Ryan commented: "The outlook for the euro area economy is far from favourable. Core inflationary pressures remain elevated, tighter monetary conditions are squeezing household spending power, and soft Chinese demand looks set to dampen export revenue. For now, we continue to expect one final interest rate increase from the European Central Bank at either its September or November meetings, although the weak growth environment suggests that an end to hikes isn't too far away. This could present a downside risk to our otherwise bullish view on EUR/USD."

Still to come on Wednesday is a US flash PMI reading at 1445 BST.

In London, pharmaceutical firms GSK and AstraZeneca, among the FTSE 100's largest constituents, added 1.6% and 0.8%.

GSK reported positive results from the first-ever efficacy trial of its preventative shingles treatment Shingrix in China. AstraZeneca and partner Daiichi Sankyo announced that their cancer drug Enhertu has received another approval in Japan.

JD Sports fell 4.0%, despite a positive start to the session. Poorly-received results from peer Foot Locker hurt the stock. Foot Locker said its sales fell 9.9% in its second quarter ended July 29. New York-listed Foot Locker said it saw a "softening in trends" in July. The stock plunged 27% in pre-market dealings.

Ithaca Energy lost 2.1%, among the worst FTSE 250 performers. The company said it has kept a lid on investments due to a UK windfall tax.

Ithaca said investment across its "operated and non-operated portfolio has and will reduce" due to the energy profits levy. It means there will be a deferral and cancellation of some projects in 2023 and 2024.

This will impact its production outlook. Ithaca expects output in 2024 to be weaker than this year's. Its guidance for 2023 was maintained at 68,000 to 74,000 barrels of oil equivalent per day.

For the first-half of the year, production rose 14% to 75,755 barrels of oil equivalent per day.

Costain added 5.2%. The construction firm is sizing up a resumption of its dividend, after a four-year break.

"The increase in operating performance and the positive outcomes regarding the pension review and refinancing, enables the board to consider the resumption of dividend payments, including the payment of an interim dividend in respect of the period to June 30," Chief Executive Officer Alex Vaughan said.

Elsewhere in London, Jadestone Energy added 28%. The Asia-Pacific-focused oil and gas firm has progressed with repairs at its Montara Venture floating production, storage and offloading vessel in Australia.

Production is temporarily shut in due to a small defect between water tank 4S and oil cargo tank 5C, but repairs have progressed in line with expectations, it said.

Stocks in New York are called to open higher on Wednesday. The Dow Jones Industrial Average is called up 0.4%, the S&P 500 up 0.5% and the Nasdaq Composite 0.6% higher.

Nvidia's stock was 0.9% higher in pre-market dealings, ahead of its quarterly results.

"That earnings focus looks to intensify today, with AI-bellwether Nvidia expected to drive sentiment across the board when they report later. Markets are expecting to see a dramatic surge in artificial intelligence-related revenues this quarter, with sales of the H100 chip providing a proxy for AI adoption and expansion," Scope Markets analyst Joshua Mahony commented.

"Nvidia earnings look to dominate tech sentiment, with the likes of Microsoft, Google, Meta, IBM, Oracle, and Amazon particularly expecting to see volatility based on the strength or weakness of Nvidia earnings. Meanwhile, markets gear up for tomorrow's Jackson Hole Symposium, with [Federal Reserve Chair] Powell's appearance on Friday providing the main event of note."

Gold was quoted at USD1,901.62 an ounce early Wednesday afternoon, higher than USD1,897.80 on Tuesday. Brent oil was trading at USD82.78 a barrel, down from USD84.25.

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
Today 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
Today 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.